|
[1] SHEN T,HUANG X,WANG YY,et al. Current status of epidemiological study on drug-induced liver injury in China[J]. J Clin Hepatol,2018,34(6):1152-1155.(in Chinese)沈弢，黄昕，王誉雅，等．我国药物性肝损伤流行病学研究现状[J]．临床肝胆病杂志，2018,34(6):1152-1155.
|
|
[2] CHEN J. Drug-induced liver injury caused by Chinese herbal medicine cannot be neglected[J]. J Clin Hepatol,2018,34(6):1169-1171.(in Chinese)陈军．不可忽视的中草药引起的药物性肝损伤[J]．临床肝胆病杂志，2018,34(6):1169-1171.
|
|
[3] FENG JC,WANG HY,ZHOU AQ,et al. A clinical analysis of22 patients with drug-induced liver injury caused by traditional Chinese medicine Periploca forresfii Sehltr[J]. Chin J Hepatol,2016,24(9):692-695.(in Chinese)冯剑春，王华雨，周安琪，等．中药黑骨藤致药物性肝损伤22例临床分析[J]．中华肝脏病杂志，2016,24(9):692-695.
|
|
[4] TIAN ZA,LI H,WU X,et al. A clinical analysis of 17 patients with drug-induced liver injury caused by Miao medicine Periploca forresfii Sehltr[J]. Chin J Integr Tradit West Med Liver Dis,2017,27(4):244-245.(in Chinese)田芝奥，李慧，吴霞，等．苗药黑骨藤致药物性肝损伤17例临床分析[J]．中西医结合肝病杂志，2017,27(4):244-245.
|
|
[5] ZHAO X,QI Y,CAI YJ. Fructus Swietenia Macrophylla-induced liver injury:A report of 2 cases[J]. J Clin Hepatol,2019,35(5):1086-1088.(in Chinese)赵曦，齐月，蔡艳俊．向天果致药物性肝损伤2例报告[J]．临床肝胆病杂志，2019,35(5):1086-1088.
|
|
[6] TAN Y,CHEN H,ZHOU X,et al. RUCAM-based assessment of liver injury byxiang-tian-guo(Swietenia macrophylla)seeds,aplant used for treatment of hypertension anddiabetes[J]. Ann Hepatol,2019,18(2):406-407.
|
|
[7] MELCHART D,HAGER S,ALBRECHT S,et al. Herbal Traditional Chinese Medicine and suspected liver injury:Apro spective study[J]. World J Hepatol,2017,9(29):1141-1157.
|
|
[8] ZHU CW,WANG HN,ZHANG YL,et al. Analysis on clinical features of liver injury in 140 cases caused by chinese medicine[J].Chin Hepatol,2019,24(4):362-364.(in Chinese)朱春雾，王海南，张亚蕾，等．140例中药肝损伤病例的临床特征分析[J]．肝脏，2019,24(4):362-364.
|
|
[9] YAO YJ,XIAO L,YANG CX,et al. Clinical and pathological features of patients with Chinese herbal drug-induced liver injury[J]. J Prac Hepatol,2016,19(4):441-444.(in Chinese)姚云洁，肖朗，杨才兴，等．中草药所致DILI患者临床和肝组织病理学特点分析[J]．实用肝脏病杂志，2016,19(4):441-444.
|
|
[10] HE TT,ZHONG XW,ZHANG N,et al. Prospective clinical study of liver injury in 187 cases caused by Chinese herbal drug and related preparation[J]. Chin Hepatol,2018,23(8):666-669.(in Chinese)何婷婷，钟学文，张宁，等．187例中草药及其制剂导致肝损伤病例前瞻性临床研究[J]．肝脏，2018,23(8):666-669.
|
|
[11] ZHU Y,NIU M,CHEN J,et al. Hepatobiliary and pancreatic:Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients[J]. J Gastroenterol Hepatol,2016,31(8):1476-1482.
|
|
[12] HE TT,ZHU Y,WANG JB,et al. Clinical characteristics of 96patients with drug-induced acute liver failure:A comparison between Traditional Chinese and Western Medicine[J]. J Tradit Chin Med,2017,37(3):286-297.
|
|
[13] LIU Y,WANG G,WU H,et al. Analysis on the influencing factors of hepatotoxicity of traditional Chinese medicine preparation[J]. China J Chin Mater Med,2017,42(16):3049-3055.(in Chinese)刘莹，汪刚，吴豪，等．中药制剂肝毒性的影响因素探析[J]．中国中药杂志，2017,42(16):3049-3055.
|
|
[14] YAN FY,XU N,WANG RJ,et al. Structural Analysis of Ginsenoside Based on DART-MS Technology[J]. J Changchun Univ Chin Med,2018,34(6):1058-1062.(in Chinese)闫福源，许宁，王任晶，等．基于DART-MS技术的人参皂苷结构分析[J]．长春中医药大学学报，2018,34(6):1058-1062.
|
|
[15] ZANG H,YOU SL,LIU FF,et al. Analysis on clinical features of liver injuries induced by Chinese traditional medicines[J].Pract Prevent Med,2013,20(9):1025-1027.(in Chinese)臧红，游绍莉，柳芳芳，等．中药药物性肝损害的临床特征及预防[J]．实用预防医学，2013,20(9):1025-1027.
|
|
[16] TANG YX. Study on the ancient and modern clinical application of dioscore bulbifera[J]. China J Chin Mater Med,1995,20(7):435.(in Chinese)唐迎雪．黄药子古今临床应用研究[J]．中国中药杂志，1995,20(7):435.
|
|
[17] HUANG ZF,HUA BC,CHEN XF,et al. Analysis of liver injury in 78 cases caused by rhizoma dioscoreae bulbiferae and related preparation[J]. Chin J Exp Med Formul,2013,19(23):295-297.(in Chinese)黄智锋，华碧春，陈小峰，等．黄药子及其制剂致肝损害78例临床分析[J]．中国实验方剂学杂志，2013,19(23):295-297.
|
DownLoad: